Tu1559 RISK OF HEPATOCELLULAR CARCINOMA AMONGST SUBCENTIMETER NODULES ON SURVEILLANCE ULTRASOUND: A SYSTEMATIC REVIEW
Leggi →
Maggio 2024
Risultati per: Linee guida per la gestione del carcinoma basocellulare
Questo è quello che abbiamo trovato per te
Tu1543 RURALITY OF RESIDENCE AND DISPARITY IN INCIDENT HEPATOCELLULAR CARCINOMA AMONG VIETNAM WAR VETERANS
Leggi →
Maggio 2024
Tu1562 ASSESSING ATEZOLIZUMAB PLUS BEVACIZUMAB TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS WITH ESOPHAGEAL-GASTRIC VARICES
Leggi →
Maggio 2024
Tu1538 RISK OF BILIARY STRICTURES AFTER RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA (HCC)
Leggi →
Maggio 2024
Tu1535 DEVELOPMENT OF ABDOMINAL VARICES IS ASSOCIATED WITH INCREASED HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED FIBROSIS AND CIRRHOSIS
Leggi →
Maggio 2024
Mo1912 MUTATION SPECTRUM OF TP53 GENE IN ESOPHAGEAL CARCINOMA WITH HIGH AMOUNT OF FUSOBACTERIUM SPECIES
Leggi →
Maggio 2024
Mo1481 RECURRENCE TRENDS IN AMPULLARY AND DISTAL BILE DUCT CARCINOMA – A NATION-WIDE ANALYSIS OF THE GERMAN CANCER REGISTRIES
Leggi →
Maggio 2024
Tu1583 MITO-LND AND (E)-AKT INHIBITOR-IV: NOVEL COMPOUNDS INDUCING ENDOPLASMIC RETICULUM STRESS AND ROS ACCUMULATION AGAINST HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1578 IMBRAVE150: EXPLORATORY EFFICACY AND SAFETY RESULTS OF HEPATOCELLULAR CARCINOMA (HCC) PATIENTS (PTS) WITH MAIN TRUNK AND/OR CONTRALATERAL PORTAL VEIN INVASION (VP4) TREATED WITH ATEZOLIZUMAB (ATEZO) + BEVACIZUMAB (BEV) VS SORAFENIB (SOR) IN A PH III STUDY
Leggi →
Maggio 2024
463 TGF-β1 INDUCED SOX18 ELEVATION PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS THROUGH TRANSCRIPTIONALLY UPREGULATING PD-L1 AND CXCL12
Leggi →
Maggio 2024
Su1716 ATYPICAL PRESENTATION OF SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A CASE REPORT AND REVIEW OF THE LITERATURE
Leggi →
Maggio 2024
Mo1488 FACTORS ASSOCIATED WITH PROLONGED DISEASE- FREE AND OVERALL SURVIVAL FOLLOWING CURATIVE HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA: AN OBSERVATIONAL STUDY
Leggi →
Maggio 2024
252 COMBINATION OF MODIFIED ALBUMIN-BILIRUBIN GRADE AND PLATELET COUNT TO PREDICT VARICES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1321 THE SURGICAL CASES OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA IN SHANXI CHANGZHI HOSPITAL IN CHINA: DEMOGRAPHICS, TUMOR CHARACTERISTICS, AND SURGICAL CARE
Leggi →
Maggio 2024
Tu1485 EARLY POSTOPERATIVE OUTCOME COMPARING CHRONIC PANCREATITIS VS. PANCREATIC HEAD CARCINOMA AFTER PYLORUSPRESERVING PANCREATIC HEAD RESECTION ACCORDING TO TRAVERSO-LONGMIRE AT A UNIVERSITY HOSPITAL
Leggi →
Maggio 2024
Sa1539 ASSOCIATION BETWEEN PAY-FOR-PERFORMANCE AND HEPATOCELLULAR CARCINOMA MORTALITY: INSIGHTS FROM A TAIWAN NATIONWIDE COHORT STUDY
Leggi →
Maggio 2024
